Augmented reality (AR), a technology that superimposes computer-generated information on a user’s view of the real world, offers a new platform to help physicians better visualize complex medical data, particularly before and during medical procedures. A new self-contained AR device aims to provide an immersive AR experience in which surgeons can interactively explore data in three dimensions.
Jihye Jang, a PhD Candidate at the Cardiac Magnetic Resonance (MR) Center at Beth Israel Deaconess Medical Center (BIDMC), and colleagues assessed AR’s potential to help cardiologists visualize myocardial scarring in the heart as they perform ventricular tachycardia ablation or other electrophysiological interventions. Myocardial scarring can occur in people who experience a heart attack and also stems from the surgical repair of congenital heart disease. The team’s findings, published in PLOS ONE, demonstrate that the new augmented reality technology confers a number of advantages.
“Augmented reality allows physicians to superimpose images, such as MRI or CT scans, as a guide during therapeutic intervention,” said Jang. “Our report shows exciting potential that having this complex 3D scar information through augmented reality during the intervention may help guide treatment and ultimately improve patient care. Physicians can now use AR to view 3D cardiac MR information with a touchless interaction in sterile environment.”
By projecting three dimensional imagery onto a glass screen worn like a diving mask on the surgeon’s face, AR provides 3D depth perception and allows surgeons to interact with the medical data without physically touching a screen or computer mouse, maintaining a sterile environment and reducing the risk of infection. In Jang and colleague’s pilot study, the researchers applied the augmented reality technique as they generated holographic 3D scar in five animal models that underwent controlled infarction and electrophysiological study.
3D holographic visualization of the scar was performed to assist assessment of the complex 3D scar architecture. An operator and mapping specialist viewed the holographic 3D scar during electrophysiological study, and completed the perceived usefulness questionnaire in the six-item usefulness scale and found it useful to have scar information during the intervention. The user could interactively explore 3D myocardial scar in the augmented reality environment that allows for the combination of holographic 3D LGE data interacting with any real-world environments, such as a surgical suite or patient’s body.
“Our report is one of the first efforts to test augmented reality in cardiovascular electrophysiological intervention,” said Jang. “Our next steps will expand the use of AR into treatments for arrhythmia by merging the scar information with electrophysiology data.”
The senior corresponding author of the paper is Reza Nezafat, PhD, scientific director of the Cardiac Magnetic Resonance Center at BIDMC. Other co-authors include colleagues from BIDMC, University of Pennsylvania and Technical University of Munich.
This work was supported by the National Institutes of Health [1R01HL129185, 1R21HL127650]; and the American Heart Association [15EIA22710040]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding.
BIDMC is in the community with Beth Israel Deaconess Hospital-Milton, Beth Israel Deaconess Hospital-Needham, Beth Israel Deaconess Hospital-Plymouth, Anna Jaques Hospital, Cambridge Health Alliance, Lawrence General Hospital, MetroWest Medical Center, Signature Healthcare, Beth Israel Deaconess HealthCare, Community Care Alliance and Atrius Health. BIDMC is also clinically affiliated with the Joslin Diabetes Center and Hebrew Rehabilitation Center and is a research partner of Dana-Farber/Harvard Cancer Center and the Jackson Laboratory. BIDMC is the official hospital of the Boston Red Sox. For more information, visit http://www.